{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:52:10Z","timestamp":1768312330359,"version":"3.49.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":778,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s13311-021-01085-8","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T16:02:38Z","timestamp":1628784158000},"page":"1564-1581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Novel Therapeutics for Neonatal Seizures"],"prefix":"10.1016","volume":"18","author":[{"given":"Julie M.","family":"Ziobro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista","family":"Eschbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e A.","family":"Shellhaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01085-8_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000109898","article-title":"Neonatal Seizures in the United States: Results of the National Hospital Discharge Survey, 1980\u20131991","volume":"15","author":"Lanska","year":"1996","journal-title":"Neuroepidemiology."},{"key":"10.1007\/s13311-021-01085-8_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/oxfordjournals.aje.a010079","article-title":"Incidence of neonatal seizures in Harris County, Texas, 1992\u20131994","volume":"150","author":"Saliba","year":"1999","journal-title":"Am J Epidemiol."},{"key":"10.1007\/s13311-021-01085-8_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2008.07.008","article-title":"Antenatal and Intrapartum Risk Factors for Seizures in Term Newborns: A Population-Based Study, California 1998\u20132002","volume":"154","author":"Glass","year":"2009","journal-title":"J Pediatr."},{"key":"10.1007\/s13311-021-01085-8_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpeds.2017.03.004","article-title":"Electrographic Seizures during the Early Postnatal Period in Preterm Infants","volume":"187","author":"Lloyd","year":"2017","journal-title":"J Pediatr"},{"key":"10.1007\/s13311-021-01085-8_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpeds.2016.03.035","article-title":"Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study","volume":"174","author":"Glass","year":"2016","journal-title":"J Pediatr."},{"key":"10.1007\/s13311-021-01085-8_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1212\/WNL.0000000000004284","article-title":"Profile of neonatal epilepsies","volume":"89","author":"Shellhaas","year":"2017","journal-title":"Neurology."},{"key":"10.1007\/s13311-021-01085-8_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.siny.2013.01.002","article-title":"Outcome following neonatal seizures","volume":"18","author":"Uria-Avellanal","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1007\/s13311-021-01085-8_bib8","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/epi.14671","article-title":"Response to antiseizure medications in neonates with acute symptomatic seizures","volume":"60","author":"Glass","year":"2019","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1007\/s13311-021-01085-8_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1113\/jphysiol.2004.062471","article-title":"Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1","volume":"557","author":"Yamada","year":"2004","journal-title":"J Physiol."},{"key":"10.1007\/s13311-021-01085-8_bib11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat Med."},{"key":"10.1007\/s13311-021-01085-8_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/16697","article-title":"The K+\/Cl\u2212 co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation","volume":"397","author":"Rivera","year":"1999","journal-title":"Nature."},{"key":"10.1007\/s13311-021-01085-8_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000497471","article-title":"How Early Can a Seizure Happen? Pathophysiological Considerations of Extremely Premature Infant Brain Development","volume":"40","author":"Carrasco","year":"2018","journal-title":"Dev Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.siny.2013.02.003","article-title":"Mechanisms and effects of seizures in the immature brain","volume":"18","author":"Nardou","year":"2013","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1007\/s13311-021-01085-8_bib15","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1523\/JNEUROSCI.1769-10.2010","article-title":"Progressive NKCC1-Dependent Neuronal Chloride Accumulation during Neonatal Seizures","volume":"30","author":"Dzhala","year":"2010","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-3806(92)90184-X","article-title":"Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures","volume":"65","author":"Stafstrom","year":"1992","journal-title":"Dev Brain Res."},{"key":"10.1007\/s13311-021-01085-8_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/1673-5374.200803","article-title":"Neonatal seizures and disruption to neurotransmitter systems","volume":"12","author":"Miller","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1007\/s13311-021-01085-8_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/WNP.0b013e31823e96d7","article-title":"The American Clinical Neurophysiology Society\u02bcs Guideline on Continuous Electroencephalography Monitoring in Neonates","volume":"28","author":"Shellhaas","year":"2011","journal-title":"J Clin Neurophysiol."},{"issue":"3","key":"10.1007\/s13311-021-01085-8_bib19","doi-asserted-by":"crossref","first-page":"e20161234","DOI":"10.1542\/peds.2016-1234","article-title":"Communication Challenges in Neonatal Encephalopathy.","volume":"138","author":"Lemmon","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"10.1007\/s13311-021-01085-8_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0883073816680747","article-title":"Parent Experience of Neonatal Encephalopathy: The Need for Family-Centered Outcomes","volume":"32","author":"Lemmon","year":"2017","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2016.10.003","article-title":"Seizures and Antiseizure Medications are Important to Parents of Newborns With Seizures","volume":"67","author":"Hill","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-021-01085-8_bib22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41390-018-0242-2","article-title":"Recommendations for the design of therapeutic trials for neonatal seizures","volume":"85","author":"Soul","year":"2019","journal-title":"Pediatr Res"},{"key":"10.1007\/s13311-021-01085-8_bib23","unstructured":"WHO Department of Mental Health and Substance Abuse, WHO Department of Maternal Newborn Child and Adolescent Health, OASI Department of Mental Retardation Unit of Neurology and Clinical Neurophysiopathology. Guidelines on neonatal seizures. [Internet]. World Health Organ. 2011. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/77756. Accessed November 30, 2020."},{"key":"10.1007\/s13311-021-01085-8_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0883073808321056","article-title":"Neonatal seizures: Treatment and treatment variability in 31 United States pediatric hospitals","volume":"24","author":"Blume","year":"2009","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib25","doi-asserted-by":"crossref","unstructured":"Dizon MLV, Rao R, Hamrick SE, et al. Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs. BMC Pediatr. 2019;19:67. Accessed November 30, 2021.","DOI":"10.1186\/s12887-019-1441-7"},{"key":"10.1007\/s13311-021-01085-8_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/jp.2016.206","article-title":"Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014","volume":"37","author":"Ahmad","year":"2017","journal-title":"J Perinatol."},{"key":"10.1007\/s13311-021-01085-8_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpeds.2016.10.039","article-title":"Treatment Duration After Acute Symptomatic Seizures in Neonates: A Multicenter Cohort Study","volume":"181","author":"Shellhaas","year":"2017","journal-title":"J Pediatr."},{"issue":"5","key":"10.1007\/s13311-021-01085-8_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0039-1698457","article-title":"Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change","volume":"38","author":"Le","year":"2021","journal-title":"Am J Perinatol"},{"key":"10.1007\/s13311-021-01085-8_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1113\/jphysiol.1989.sp017762","article-title":"Giant synaptic potentials in immature rat CA3 hippocampal neurones","volume":"416","author":"Ben-Ari","year":"1989","journal-title":"J Physiol."},{"key":"10.1007\/s13311-021-01085-8_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0736-5748(90)90080-L","article-title":"GABA mediated excitation in immature rat CA3 hippocampal neurons","volume":"8","author":"Cherubini","year":"1990","journal-title":"Int J Dev Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib31","unstructured":"Sharpe C, Reiner GE, Davis SL, et al. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics [Internet]. 2020;145:e20193182. Available at: https:\/\/pediatrics.aappublications.org. Accessed January 1, 2021."},{"key":"10.1007\/s13311-021-01085-8_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1167.2011.03401.x","article-title":"The temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathy","volume":"53","author":"Lynch","year":"2012","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/epi.13990","article-title":"Neonatal phenobarbital exposure disrupts GABAergic synaptic maturation in rat CA1 neurons","volume":"59","author":"Al-Muhtasib","year":"2018","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/epi.13365","article-title":"Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain","volume":"57","author":"Kaushal","year":"2016","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib35","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1111\/j.1528-1167.2011.03297.x","article-title":"Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain","volume":"52","author":"Forcelli","year":"2011","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib36","doi-asserted-by":"crossref","first-page":"105245","DOI":"10.1016\/j.nbd.2020.105245","article-title":"Brain pathology caused in the neonatal macaque by short and prolonged exposures to anticonvulsant drugs.","volume":"149","author":"Noguchi","year":"2021","journal-title":"Neurobiol Dis."},{"key":"10.1007\/s13311-021-01085-8_bib37","doi-asserted-by":"crossref","unstructured":"Quinlan SMM, Rodriguez-Alvarez N, Molloy EJ, et al. Complex spectrum of phenobarbital effects in a mouse model of neonatal hypoxia-induced seizures. Sci Rep [Internet]. 2018;8:9986. Available from: https:\/\/www.nature.com\/articles\/s41598-018-28044-2. Accessed January 1, 2021.","DOI":"10.1038\/s41598-018-28044-2"},{"key":"10.1007\/s13311-021-01085-8_bib38","article-title":"[cited 2020 Dec 30];340:558\u2013566","author":"Forcelli","year":"2012","journal-title":"Available from:"},{"key":"10.1007\/s13311-021-01085-8_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/13895260500327979","article-title":"A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy","volume":"18","author":"Singh","year":"2005","journal-title":"J Matern Neonatal Med."},{"key":"10.1007\/s13311-021-01085-8_bib40","doi-asserted-by":"crossref","unstructured":"Young L, Berg M, Soll R. Prophylactic barbiturate use for the prevention of morbidity and mortality following perinatal asphyxia. Cochrane Database Syst. Rev.[Internet]; 2016:5(5):CD001240. Available from: https:\/\/doi.org\/10.1002\/14651858.CD001240.pub3\/full. Accessed December 30, 2020.","DOI":"10.1002\/14651858.CD001240.pub3"},{"key":"10.1007\/s13311-021-01085-8_bib41","first-page":"617","article-title":"Evaluation of two fosphenytoin loading dose regimens and monitoring in infants and neonates less than six months of age","volume":"25","author":"Bohannon","year":"2020","journal-title":"J Pediatr Pharmacol Ther."},{"key":"10.1007\/s13311-021-01085-8_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0883073898013001061","article-title":"Clinical experience with fosphenytoin in children","volume":"13","author":"Morton","year":"1998","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.ftd.0000249948.95749.f3","article-title":"Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures","volume":"28","author":"Al Za'abi","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1007\/s13311-021-01085-8_bib44","doi-asserted-by":"crossref","unstructured":"Alix V, James M, Jackson AH, et al. Efficacy of Fosphenytoin as First-Line Antiseizure Medication for Neonatal Seizures Compared to Phenobarbital. J Child Neurol. 2021;36:30-37.","DOI":"10.1177\/0883073820947514"},{"key":"10.1007\/s13311-021-01085-8_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0387-7604(99)00110-2","article-title":"Phenytoin administration in the newborn and infant","volume":"22","author":"Sicca","year":"2000","journal-title":"Brain Dev."},{"key":"10.1007\/s13311-021-01085-8_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0887-8994(00)00263-0","article-title":"Fosphenytoin in infants of extremely low birth weight","volume":"24","author":"Kriel","year":"2001","journal-title":"Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/088307389801301102","article-title":"Fosphenytoin in Infants","volume":"13","author":"Takeoka","year":"1997","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib48","doi-asserted-by":"crossref","unstructured":"Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci. 2003;993:103-114.","DOI":"10.1111\/j.1749-6632.2003.tb07517.x"},{"key":"10.1007\/s13311-021-01085-8_bib49","doi-asserted-by":"crossref","unstructured":"Grinspan ZM, Shellhaas RA, Coryell J, et al. Comparative effectiveness of levetiracetam vs phenobarbital for infantile epilepsy. JAMA Pediatr. 2018;172:352-360.","DOI":"10.1001\/jamapediatrics.2017.5211"},{"key":"10.1007\/s13311-021-01085-8_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: Safety and efficacy in neonatal seizures","volume":"15","author":"Ramantani","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1007\/s13311-021-01085-8_bib52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pediatrneurol.2013.05.008","article-title":"Role of intravenous levetiracetam for acute seizure management in preterm neonates","volume":"49","author":"Khan","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1007\/s13311-021-01085-8_bib53","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/s41372-019-0498-3","article-title":"Lack of response to treatment with levetiracetam in extreme preterm infants with seizures.","volume":"39","author":"Kurtom","year":"2019","journal-title":"J Perinatol."},{"key":"10.1007\/s13311-021-01085-8_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-018-1103-1","article-title":"Efficacy of levetiracetam for neonatal seizures in preterm infants","volume":"18","author":"Han","year":"2018","journal-title":"BMC Pediatr."},{"key":"10.1007\/s13311-021-01085-8_bib55","article-title":"cited 2020 Dec 30","author":"Strasser","year":"2016","journal-title":"Available from:"},{"key":"10.1007\/s13311-021-01085-8_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3683548","article-title":"Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: A single-center experience","author":"Falsaperla","year":"2019","journal-title":"Behav Neurol"},{"key":"10.1007\/s13311-021-01085-8_bib57","doi-asserted-by":"crossref","unstructured":"Arican P, Olgac Dundar N, Mete Atasever N, et al. Comparison of the neurocognitive outcomes in term infants treated with levetiracetam and phenobarbital monotherapy for neonatal clinical seizures. Seizure [Internet]. 2020;80:71\u201374. Available at: https:\/\/www.seizure-journal.com. Accessed November 30, 2020.","DOI":"10.1016\/j.seizure.2020.06.006"},{"key":"10.1007\/s13311-021-01085-8_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/WNP.0b013e3182872b24","article-title":"American clinical neurophysiology society standardized EEG terminology and categorization for the description of continuous eeg monitoring in neonates: Report of the american clinical neurophysiology society critical care monitoring committee","volume":"30","author":"Tsuchida","year":"2013","journal-title":"J Clin Neurophysiol."},{"key":"10.1007\/s13311-021-01085-8_bib59","doi-asserted-by":"crossref","unstructured":"Pavlidis E, Spagnoli C, Pelosi A, et al. Neonatal status epilepticus: Differences between preterm and term newborns. Eur J Paediatr Neurol [Internet]. 2015;19:314\u2013319. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.ejpn.2015.01.002. Accessed November 30, 2020.","DOI":"10.1016\/j.ejpn.2015.01.002"},{"key":"10.1007\/s13311-021-01085-8_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.24967","article-title":"Phenobarbital and midazolam increase neonatal seizure-associated neuronal injury","volume":"82","author":"Torolira","year":"2017","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib61","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ped.13554","article-title":"Midazolam as a first-line treatment for neonatal seizures: Retrospective study","volume":"60","author":"Dao","year":"2018","journal-title":"Pediatr Int."},{"key":"10.1007\/s13311-021-01085-8_bib62","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/01.WNL.0000152891.58694.71","article-title":"Midazolam in neonatal seizures with no response to phenobarbital","volume":"64","author":"Castro Conde","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-021-01085-8_bib63","doi-asserted-by":"crossref","unstructured":"Boylan GB, Rennie JM, Chorley G, et al. Second-line anticonvulsant treatment of neonatal seizures: A video-EEG monitoring study. Neurology. 2004;62:486-488.","DOI":"10.1212\/01.WNL.0000106944.59990.E6"},{"key":"10.1007\/s13311-021-01085-8_bib64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0883073807299858","article-title":"Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures","volume":"22","author":"Shany","year":"2007","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib65","doi-asserted-by":"crossref","unstructured":"Duerden EG, Guo T, Dodbiba L, et al. Midazolam Dose Correlates with Abnormal Hippocampal Growth and Neurodevelopmental Outcome in Preterm Infants. Ann Neurol. 2016;79:548-559.","DOI":"10.1002\/ana.24601"},{"key":"10.1007\/s13311-021-01085-8_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/bcp.14136","article-title":"Lidocaine as treatment for neonatal seizures: Evaluation of previously developed population pharmacokinetic models and dosing regimen","volume":"86","author":"Favi\u00e9","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"10.1007\/s13311-021-01085-8_bib67","doi-asserted-by":"crossref","unstructured":"Malingr\u00e9 MM, Van Rooij LGM, Rademaker CMA, et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr. 2006;165:598\u2013604.","DOI":"10.1007\/s00431-006-0136-x"},{"key":"10.1007\/s13311-021-01085-8_bib68","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/11589160-000000000-00000","article-title":"Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures","volume":"50","author":"Van Den Broek","year":"2011","journal-title":"Clin Pharmacokinet."},{"key":"10.1007\/s13311-021-01085-8_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/epi.13286","article-title":"Lidocaine response rate in aEEG-confirmed neonatal seizures: Retrospective study of 413 full-term and preterm infants","volume":"57","author":"Weeke","year":"2016","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib70","doi-asserted-by":"crossref","unstructured":"Van Rooij LGM, Toet MC, Rademaker KMA, et al. Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. Eur. J. Pediatr. 2004;163:637\u2013641.","DOI":"10.1007\/s00431-004-1513-y"},{"key":"10.1007\/s13311-021-01085-8_bib71","doi-asserted-by":"crossref","unstructured":"Weeke LC, Schalkwijk S, Toet MC, et al. Lidocaine-Associated Cardiac Events in Newborns with Seizures: Incidence, Symptoms and Contributing Factors. Neonatology [Internet]. 2015;108:130\u2013136. Available from: www.karger.com\/neo. Accessed January 1, 2021.","DOI":"10.1159\/000430767"},{"key":"10.1007\/s13311-021-01085-8_bib72","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.21229","article-title":"Bumetanide enhances phenobarbital efficacy in a neonatal seizure model","volume":"63","author":"Dzhala","year":"2008","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib73","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/epi.16778","article-title":"Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective","volume":"62","author":"Johne","year":"2021","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib74","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/epi.12620","article-title":"Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures","volume":"55","author":"Puskarjov","year":"2014","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): An open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib76","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2015.74","article-title":"Epilepsy: Neonatal seizure still lack safe and effective treatment","volume":"11","author":"Thoresen","year":"2015","journal-title":"Nat Rev - Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib77","doi-asserted-by":"crossref","unstructured":"Soul JS, Bergin AM, Stopp C, et al. A Pilot Randomized, Controlled, Double\u2010Blind Trial of Bumetanide to Treat Neonatal Seizures. Ann Neurol. 2021;89:327-340.","DOI":"10.1002\/ana.25959"},{"key":"10.1007\/s13311-021-01085-8_bib78","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1523\/JNEUROSCI.0477-04.2004","article-title":"Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate","volume":"24","author":"Follett","year":"2004","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2004.01.025","article-title":"Therapeutic doses of topiramate are not toxic to the developing rat brain","volume":"187","author":"Glier","year":"2004","journal-title":"Exp Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","article-title":"Off-Label Use of Antiepileptic Drugs for the Treatment of Neonatal Seizures","volume":"39","author":"Silverstein","year":"2008","journal-title":"Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000499084","article-title":"Topiramate plus cooling for hypoxic-ischemic encephalopathy: A randomized, controlled, multicenter, double-blinded trial","volume":"116","author":"Nu\u00f1ez-Ramiro","year":"2019","journal-title":"Neonatology."},{"key":"10.1007\/s13311-021-01085-8_bib82","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14767058.2017.1304536","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study","volume":"31","author":"Filippi","year":"2018","journal-title":"J Matern Neonatal Med."},{"key":"10.1007\/s13311-021-01085-8_bib83","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2011.01.006","article-title":"Topiramate for the treatment of neonatal seizures","volume":"44","author":"Glass","year":"2011","journal-title":"Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib84","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/epi.12973","article-title":"Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats","volume":"56","author":"Dupuis","year":"2015","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib85","doi-asserted-by":"crossref","unstructured":"Nissenkorn A, Tzadok M, Bar-Yosef O, et al. Treatment with brivaracetam in children \u2013 The experience of a pediatric epilepsy center. Epilepsy Behav. 2019;101(PtA):106541.","DOI":"10.1016\/j.yebeh.2019.106541"},{"key":"10.1007\/s13311-021-01085-8_bib86","doi-asserted-by":"crossref","unstructured":"Liu E, Dilley D, McDonough B, et al. Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial. Pediatr Drugs. 2019;21:291\u2013301.","DOI":"10.1007\/s40272-019-00332-y"},{"key":"10.1007\/s13311-021-01085-8_bib87","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0883073819879276","article-title":"Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience","volume":"35","author":"McGuire","year":"2020","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib88","doi-asserted-by":"crossref","unstructured":"Welsh SS, Lin N, Topjian AA, et al. Safety of intravenous lacosamide in critically ill children. Seizure. 2017;52:76\u201380.","DOI":"10.1016\/j.seizure.2017.09.019"},{"key":"10.1007\/s13311-021-01085-8_bib89","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/epi.12196","article-title":"Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model","volume":"54","author":"Licko","year":"2013","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12028-012-9808-8","article-title":"Lacosamide improves outcome in a murine model of traumatic brain injury","volume":"19","author":"Wang","year":"2013","journal-title":"Neurocrit Care."},{"key":"10.1007\/s13311-021-01085-8_bib91","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3988\/jcn.2017.13.2.138","article-title":"Neuroprotective effect of lacosamide on hypoxic-ischemic brain injury in neonatal rats","volume":"13","author":"Kim","year":"2017","journal-title":"J Clin Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib92","doi-asserted-by":"crossref","unstructured":"Arkilo D, Gustafson M, Ritter FJ. Clinical experience of intravenous lacosamide in infants and young children. Eur J Paediatr Neurol. 2016;20:212\u2013217.","DOI":"10.1016\/j.ejpn.2015.12.013"},{"key":"10.1007\/s13311-021-01085-8_bib93","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1684\/epd.2018.1001","article-title":"Lacosamide for SCN2A-related intractable neonatal and infantile seizures","volume":"20","author":"Hadar","year":"2018","journal-title":"Epileptic Disord."},{"key":"10.1007\/s13311-021-01085-8_bib94","doi-asserted-by":"crossref","unstructured":"Naylor DE, Liu H, Wasterlain CG. Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. 2005;25:7724\u20137733.","DOI":"10.1523\/JNEUROSCI.4944-04.2005"},{"key":"10.1007\/s13311-021-01085-8_bib95","doi-asserted-by":"crossref","unstructured":"Chen J, Naylor DE, Wasterlain CG. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand. 2007;186:7\u201315.","DOI":"10.1111\/j.1600-0404.2007.00803.x"},{"key":"10.1007\/s13311-021-01085-8_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-Methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett."},{"key":"10.1007\/s13311-021-01085-8_bib97","doi-asserted-by":"crossref","unstructured":"Wasterlain CG, Chen JWY. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49:63-73.","DOI":"10.1111\/j.1528-1167.2008.01928.x"},{"key":"10.1007\/s13311-021-01085-8_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01333-X","article-title":"Effect of ketamine on hypoxic\u2013ischemic brain damage in newborn rats","volume":"819","author":"Spandou","year":"1999","journal-title":"Brain Res."},{"key":"10.1007\/s13311-021-01085-8_bib99","doi-asserted-by":"crossref","unstructured":"Brambrink AM, Evers AS, Avidan MS, et al. Ketamine-induced Neuroapoptosis in the Fetal and Neonatal Rhesus Macaque Brain. Anesthesiology. 2012;116:372\u2013384.","DOI":"10.1097\/ALN.0b013e318242b2cd"},{"key":"10.1007\/s13311-021-01085-8_bib100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ntt.2011.01.001","article-title":"Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys","volume":"33","author":"Paule","year":"2011","journal-title":"Neurotoxicol Teratol."},{"key":"10.1007\/s13311-021-01085-8_bib101","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.arcped.2018.03.001","article-title":"Prospective follow-up of a cohort of preterm infants < 33 WG receiving ketamine for tracheal intubation in the delivery room: Neurological outcome at 1 and 2 years","volume":"25","author":"Elalouf","year":"2018","journal-title":"Arch Pediatr."},{"key":"10.1007\/s13311-021-01085-8_bib102","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pediatrneurol.2014.03.006","article-title":"Use of ketamine in a newborn with refractory status epilepticus: A case report","volume":"51","author":"Tarocco","year":"2014","journal-title":"Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1684\/epd.2018.1011","article-title":"KCNQ2 mutation in an infant with encephalopathy of infancy with migrating focal seizures","volume":"20","author":"Freibauer","year":"2018","journal-title":"Epileptic Disord."},{"key":"10.1007\/s13311-021-01085-8_bib104","doi-asserted-by":"crossref","unstructured":"H\u00f6fler J, Trinka E. Intravenous ketamine in status epilepticus. Epilepsia. 2018;59:198-206.","DOI":"10.1111\/epi.14480"},{"key":"10.1007\/s13311-021-01085-8_bib105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pediatrneurol.2008.10.025","article-title":"Animal Models of Perinatal Hypoxic-Ischemic Brain Damage","volume":"40","author":"Yager","year":"2009","journal-title":"Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jneumeth.2015.09.023","article-title":"Models of hypoxia and ischemia-induced seizures","volume":"260","author":"Sun","year":"2016","journal-title":"J Neurosci Methods."},{"key":"10.1007\/s13311-021-01085-8_bib107","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0024-3205(85)90478-3","article-title":"Long-term effect of postnatal hypoxia on the seizure susceptibility in rats","volume":"37","author":"Chiba","year":"1985","journal-title":"Life Sci."},{"key":"10.1007\/s13311-021-01085-8_bib108","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410290610","article-title":"Epileptogenic effect of hypoxia in the immature rodent brain","volume":"29","author":"Jensen","year":"1991","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib109","first-page":"1","article-title":"Anoxic-Ischemic Encephalopathy in Rats","volume":"36","author":"Levine","year":"1960","journal-title":"Am J Pathol."},{"key":"10.1007\/s13311-021-01085-8_bib110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.410090206","article-title":"The influence of immaturity on hypoxic-ischemic brain damage in the rat","volume":"9","author":"Rice","year":"1981","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib111","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhang M, Liu S, et al. Xenon exerts anti-seizure and neuroprotective effects in kainic acid-induced status epilepticus and neonatal hypoxia-induced seizure. Exp Neurol. 2019;322:113054.","DOI":"10.1016\/j.expneurol.2019.113054"},{"key":"10.1007\/s13311-021-01085-8_bib112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yebeh.2019.03.037","article-title":"High seizure load during sensitive periods of development leads to broad shifts in ultrasonic vocalization behavior in neonatal male and female C57BL\/6J mice","volume":"95","author":"Nolan","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1007\/s13311-021-01085-8_bib113","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1460-9568.2012.08140.x","article-title":"Neonatal seizures: Controversies and challenges in translating new therapies from the lab to the isolette","volume":"35","author":"Chapman","year":"2012","journal-title":"Eur J Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib114","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/0970-9185.94833","article-title":"Flupirtine: Clinical pharmacology","volume":"28","author":"Harish","year":"2012","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"10.1007\/s13311-021-01085-8_bib115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.21593","article-title":"A KCNQ channel opener for experimental neonatal seizures and status epilepticus","volume":"65","author":"Raol","year":"2009","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib116","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2015.09.005","article-title":"Flupirtine effectively prevents development of acute neonatal seizures in an animal model of global hypoxia","volume":"607","author":"Sampath","year":"2015","journal-title":"Neurosci Lett."},{"key":"10.1007\/s13311-021-01085-8_bib117","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuropharm.2017.06.002","article-title":"Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy","volume":"123","author":"Sampath","year":"2017","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-021-01085-8_bib118","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41390-019-0734-8","article-title":"Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic\u2013ischemic injury","volume":"88","author":"Sampath","year":"2020","journal-title":"Pediatr Res."},{"key":"10.1007\/s13311-021-01085-8_bib119","unstructured":"European Medicines Agency. Withdrawal of pain medicine flupirtine endorsed [Internet]. 2018. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/flupirtine-article-31-referral-withdrawal-pain-medicine-flupirtine-endorsed_en.pdf. Accessed January 2, 2021."},{"key":"10.1007\/s13311-021-01085-8_bib120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2012.03.006","article-title":"Anticonvulsant effect of retigabine during postnatal development in rats","volume":"101","author":"Forcelli","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1007\/s13311-021-01085-8_bib121","doi-asserted-by":"crossref","unstructured":"Millichap JJ, Park KL, Tsuchida T, et al. KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients. Neurol Genet. 2016;2;e96.","DOI":"10.1212\/NXG.0000000000000096"},{"key":"10.1007\/s13311-021-01085-8_bib122","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1111\/ejn.13094","article-title":"Acute TrkB inhibition rescues phenobarbital-resistant seizures in a mouse model of neonatal ischemia","volume":"42","author":"Kang","year":"2015","journal-title":"Eur J Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib123","doi-asserted-by":"crossref","unstructured":"Carter BM, Sullivan BJ, Landers JR, et al. Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12. Sci Rep. 2018;8:11987.","DOI":"10.1038\/s41598-018-30486-7"},{"key":"10.1007\/s13311-021-01085-8_bib124","doi-asserted-by":"crossref","unstructured":"Kang SK, Ammanuel S, Adler DA, et al. Rescue of PB-resistant neonatal seizures with single-dose of small-molecule TrkB antagonist show long-term benefits. Epilepsy Res. 2020;159:106249.","DOI":"10.1016\/j.eplepsyres.2019.106249"},{"key":"10.1007\/s13311-021-01085-8_bib125","doi-asserted-by":"crossref","unstructured":"Kipnis PA, Sullivan BJ, Carter BM, et al. TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice. JCI Insight. 2020;5:e136007.","DOI":"10.1172\/jci.insight.136007"},{"key":"10.1007\/s13311-021-01085-8_bib126","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eplepsyres.2014.01.019","article-title":"Lestaurtinib (CEP-701) attenuates \u201csecond hit\u201d kainic acid-induced seizures following early life hypoxic seizures","volume":"108","author":"Obeid","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1007\/s13311-021-01085-8_bib127","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/epi.13842","article-title":"Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats","volume":"58","author":"Huizenga","year":"2017","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2019.01.002","article-title":"Preclinical safety and efficacy of cannabidivarin for early life seizures","volume":"148","author":"Huizenga","year":"2019","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-021-01085-8_bib129","first-page":"98","article-title":"Cannabis use during pregnancy and postpartum","volume":"66","author":"Badowski","year":"2020","journal-title":"Can Fam Physician."},{"key":"10.1007\/s13311-021-01085-8_bib130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0040-1702943","article-title":"Neonatal Seizures: Diagnosis, Etiologies, and Management","volume":"40","author":"Ziobro","year":"2020","journal-title":"Semin Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib131","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/epi.16583","article-title":"2-Deoxyglucose terminates pilocarpine-induced status epilepticus in neonatal rats","volume":"61","author":"Janicot","year":"2020","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib132","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13041-019-0465-0","article-title":"Gluconate suppresses seizure activity in developing brains by inhibiting CLC-3 chloride channels","volume":"12","author":"Wu","year":"2019","journal-title":"Mol Brain."},{"key":"10.1007\/s13311-021-01085-8_bib133","doi-asserted-by":"crossref","unstructured":"Grosenbaugh DK, Ross BM, Wagley P, et al. The Role of Kainate Receptors in the Pathophysiology of Hypoxia-Induced Seizures in the Neonatal Mouse. Sci Rep. 2018;8:7035.","DOI":"10.1038\/s41598-018-24722-3"},{"key":"10.1007\/s13311-021-01085-8_bib134","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1528-1167.2008.01947.x","article-title":"Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model","volume":"50","author":"Aujla","year":"2009","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/bk-1978-0083.ch002","article-title":"Structure-activity relationships of aminobenzoic acid diuretics and related compounds (1)","volume":"83","author":"Nielsen","year":"1978","journal-title":"Diuret Agens."},{"key":"10.1007\/s13311-021-01085-8_bib136","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuropharm.2018.09.025","article-title":"Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy","volume":"143","author":"Brandt","year":"2018","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-021-01085-8_bib137","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0883073807301917","article-title":"Seizure recurrence and developmental disabilities after neonatal seizures: Outcomes are unrelated to use of phenobarbital prophylaxis","volume":"22","author":"Guillet","year":"2007","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib138","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0883073817745990","article-title":"Provider Practices of Phenobarbital Discontinuation in Neonatal Seizures","volume":"33","author":"Natarajan","year":"2018","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib139","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/epi.13745","article-title":"Early discontinuation of antiseizure medications in neonates with hypoxic\u2013ischemic encephalopathy","volume":"58","author":"Fitzgerald","year":"2017","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib140","unstructured":"Glass HC, Soul JS, Chan T, et al. Duration of antiseizure medication treatment and 2-year outcome after acute symptomatic neonatal seizures - a Neonatal Seizure Registry study. 16th Int Child Neurol Virtual Congr. 2020."},{"key":"10.1007\/s13311-021-01085-8_bib141","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","article-title":"Neonatal Seizures: Multicenter Variability in Current Treatment Practices","volume":"37","author":"Bartha","year":"2007","journal-title":"Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib142","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0883073814553799","article-title":"Neonatal neurocritical care service is associated with decreased administration of seizure medication","volume":"30","author":"Wietstock","year":"2015","journal-title":"J Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib143","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.siny.2018.01.004","article-title":"Neonatal epilepsies: Clinical management","volume":"23","author":"Cornet","year":"2018","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1007\/s13311-021-01085-8_bib144","doi-asserted-by":"crossref","unstructured":"Kaur S, Pappas K. Genetic Etiologies of Neonatal Seizures. Neoreviews. 2020;21:e663-e672.","DOI":"10.1542\/neo.21-10-e663"},{"key":"10.1007\/s13311-021-01085-8_bib145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/acn3.51128","article-title":"Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?","volume":"7","author":"Moavero","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib146","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/dmcn.14356","article-title":"Long-term cognitive outcomes in tuberous sclerosis complex","volume":"62","author":"Tye","year":"2020","journal-title":"Dev Med Child Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib147","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000448639","article-title":"Genetic basis of brain malformations","volume":"7","author":"Parrini","year":"2016","journal-title":"Mol Syndromol."},{"key":"10.1007\/s13311-021-01085-8_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1077-6","article-title":"Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - A multicenter retrospective study","volume":"14","author":"Saffari","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"10.1007\/s13311-021-01085-8_bib149","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/epi.13057","article-title":"Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics","volume":"56","author":"Wilmshurst","year":"2015","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.spen.2016.06.004","article-title":"Amenable Treatable Severe Pediatric Epilepsies","volume":"23","author":"Pearl","year":"2016","journal-title":"Semin Pediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib151","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(15)00124-5","article-title":"Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: A prospective cohort study","volume":"386","author":"Schwahn","year":"2015","journal-title":"Lancet."},{"key":"10.1007\/s13311-021-01085-8_bib152","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00439-019-01992-z","article-title":"Molybdenum cofactor deficiency type B knock-in mouse models carrying patient-identical mutations and their rescue by singular AAV injections","volume":"138","author":"Reiss","year":"2019","journal-title":"Hum Genet."},{"key":"10.1007\/s13311-021-01085-8_bib153","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17446651.2017.1273107","article-title":"Current knowledge for pyridoxine-dependent epilepsy: a 2016 update","volume":"12","author":"Pena","year":"2017","journal-title":"Expert Rev Endocrinol Metab."},{"key":"10.1007\/s13311-021-01085-8_bib154","doi-asserted-by":"crossref","unstructured":"P\u00e9rez B, Guti\u00e9rrez-Solana LG, Verd\u00fa A, et al. Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option. Epilepsia. 2013;54:239\u2013248.","DOI":"10.1111\/epi.12083"},{"key":"10.1007\/s13311-021-01085-8_bib155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11011-016-9933-8","article-title":"Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy","volume":"32","author":"Al Teneiji","year":"2017","journal-title":"Metab Brain Dis."},{"key":"10.1007\/s13311-021-01085-8_bib156","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1089\/hum.2019.190","article-title":"Gene-Based Approaches to Inherited Neurometabolic Diseases","volume":"30","author":"Poletti","year":"2019","journal-title":"Hum Gene Ther."},{"key":"10.1007\/s13311-021-01085-8_bib157","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2016.06.006","article-title":"Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model","volume":"119","author":"Hinderer","year":"2016","journal-title":"Mol Genet Metab."},{"key":"10.1007\/s13311-021-01085-8_bib158","doi-asserted-by":"crossref","unstructured":"Pearl PL. Epilepsy Syndromes in Childhood. Continuum. 2018;24:186\u2013209.","DOI":"10.1212\/CON.0000000000000568"},{"key":"10.1007\/s13311-021-01085-8_bib159","doi-asserted-by":"crossref","unstructured":"Maljevic S, Lerche H. Potassium channel genes and benign familial neonatal epilepsy. Prog Brain Res. 2014;213:17-53.","DOI":"10.1016\/B978-0-444-63326-2.00002-8"},{"key":"10.1007\/s13311-021-01085-8_bib160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14737175.2017.1253476","article-title":"Precision medicine in genetic epilepsies: break of dawn?","volume":"17","author":"Reif","year":"2017","journal-title":"Expert Rev Neurother."},{"key":"10.1007\/s13311-021-01085-8_bib161","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/epi.12984","article-title":"Early and effective treatment of KCNQ2 encephalopathy","volume":"56","author":"Pisano","year":"2015","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib162","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/epi.16386","article-title":"SCN1A-related phenotypes: Epilepsy and beyond","volume":"60","author":"Scheffer","year":"2019","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib163","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1212\/WNL.0000000000004331","article-title":"Not all SCN1A epileptic encephalopathies are Dravet syndrome","volume":"89","author":"Sadleir","year":"2017","journal-title":"Neurology."},{"key":"10.1007\/s13311-021-01085-8_bib164","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.25438","article-title":"SCN1A gain of function in early infantile encephalopathy","volume":"85","author":"Berecki","year":"2019","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpn.2019.12.016","article-title":"The phenotypic spectrum of SCN2A-related epilepsy","volume":"24","author":"Reynolds","year":"2020","journal-title":"Eur J Paediatr Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib166","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/brain\/awx054","article-title":"Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders","volume":"140","author":"Wolff","year":"2017","journal-title":"Brain."},{"key":"10.1007\/s13311-021-01085-8_bib167","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/brain\/awt073","article-title":"Migrating partial seizures of infancy: Expansion of the electroclinical, radiological and pathological disease spectrum","volume":"136","author":"McTague","year":"2013","journal-title":"Brain."},{"key":"10.1007\/s13311-021-01085-8_bib168","doi-asserted-by":"crossref","unstructured":"Milligan CJ, Li M, Gazina EV, et al. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Ann Neurol. 2014;75:581-590.","DOI":"10.1002\/ana.24128"},{"key":"10.1007\/s13311-021-01085-8_bib169","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/ana.24520","article-title":"Quinidine in the treatment of KCNT1-positive epilepsies","volume":"78","author":"Mikati","year":"2015","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.24229","article-title":"Targeted treatment of migrating partial seizures of infancy with quinidine","volume":"76","author":"Bearden","year":"2014","journal-title":"Ann Neurol."},{"key":"10.1007\/s13311-021-01085-8_bib171","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/epi.16480","article-title":"KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases","volume":"61","author":"Borlot","year":"2020","journal-title":"Epilepsia."},{"key":"10.1007\/s13311-021-01085-8_bib172","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s13311-019-00739-y","article-title":"Treatment Responsiveness in KCNT1-Related Epilepsy","volume":"16","author":"Fitzgerald","year":"2019","journal-title":"Neurotherapeutics."},{"key":"10.1007\/s13311-021-01085-8_bib173","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mcn.2016.01.004","article-title":"Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy","volume":"72","author":"Rizzo","year":"2016","journal-title":"Mol Cell Neurosci."},{"key":"10.1007\/s13311-021-01085-8_bib174","doi-asserted-by":"crossref","unstructured":"Pressler RM, Lagae L. Why we urgently need improved seizure and epilepsy therapies for children and neonates. Neuropharmacology. 2020;170:107854.","DOI":"10.1016\/j.neuropharm.2019.107854"},{"key":"10.1007\/s13311-021-01085-8_bib175","doi-asserted-by":"crossref","unstructured":"Grinspan ZM, Patel AD, Shellhaas RA, et al. Design and implementation of electronic health record common data elements for pediatric epilepsy: Foundations for a learning health care system. Epilepsia. 2021;62:198-216.","DOI":"10.1111\/epi.16733"},{"key":"10.1007\/s13311-021-01085-8_bib176","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/epi.13661","article-title":"Interrater agreement in the interpretation of neonatal electroencephalography in hypoxic-ischemic encephalopathy","volume":"58","author":"Wusthoff","year":"2017","journal-title":"Epilepsia."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01085-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01085-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01085-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:44:05Z","timestamp":1761806645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923007560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":176,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1878747923007560"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01085-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Therapeutics for Neonatal Seizures","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01085-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}